verified SJR 0,659 · Q2 • database Scopus / SJR & Web of Science indexed

United Kingdom · Taylor and Francis Ltd.

workspace_premium Q2 — Medicine (miscellaneous) lock Subscription

Expert Review of Cardiovascular Therapy

Expert Review of Cardiovascular Therapy is a journal indexed in SJR in Medicine (miscellaneous) and Internal Medicine with an H index of 65. It has a price of 4000 €. It has an SJR impact factor of 0,659 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,659.

Expert Review of Cardiovascular Therapy focuses its scope in these topics and keywords: cardiovascular, platelet, willebrand, von, risk, aging, factor, venous, disease, growing, ...

ISSN: 1477-9072

Publisher: Taylor and Francis Ltd.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,659 Q2

H-index 65

Acceptance rate pie_chart

29% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

4.000 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,659

H-index

Docs (year)

Docs 3y

287

Total refs

4504

Cites 3y

554

Citable 3y

252

Cites/Doc 2y

1.93

Ref/Doc

70.38

Immediate OA

4000 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bicuspid aortic valve disease: recent insights in pathophysiology and treatment

Vascular protectants for the treatment of atherosclerosis

Clinical significance of atrial fibrillation after myocardial infarction

Cell and gene therapy for severe heart failure patients: The time and place for Pim-1 kinase

Cardiovascular magnetic resonance imaging of myocardial inflammation

Cardiovascular effects of selective cyclooxygenase-2 inhibitors

Cardiac resynchronization therapy in mildly symptomatic heart failure: the earlier the better

Candesartan cilexetil in the management of blood pressure for acute and recurrent stroke in Japan: the Challenge-Stroke study

Can endovascular therapy of infrainguinal disease for claudication be justified?

Can antiarrhythmic drugs save lives in patients with congestive heart failure?

Brugada syndrome: clinical, genetic, molecular, cellular and ionic aspects

Bosentan

SHOW MORE ARTICLES

Bivalirudin: an anticoagulant option for percutaneous coronary intervention

A comparison of alternative access routes for transcatheter aortic valve implantation

Atheroma of the aortic arch: the missing link in the secondary prevention of stroke?

Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use

Angiotensin-receptor blockade in renal disease: the hard issues

An update on peripartum cardiomyopathy

Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease

Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension

Advanced life support therapy on out-of-hospital cardiac arrest patients: an engineering perspective

Adiponectin: linking the metabolic syndrome to its cardiovascular consequences

Acute stroke hypertension: current and future management

Acute aortic syndromes: aortic dissections, penetrating aortic ulcers and intramural aortic hematomas

FAQs

Expert Review of Cardiovascular Therapy has an SJR of 0,659 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 4000 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Expert Review of Cardiovascular Therapy is 29%.

Expert Review of Cardiovascular Therapy

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Expert Review of Cardiovascular Therapy?

What is the APC / publication cost?

What is the acceptance rate?